IPC Healthcare Private Limited

• Zidlife-AV® contains a combination of Ceftazidime and Avibactam for injection.

• Ceftazidime is a third-generation cephalosporin antibiotic, and Avibactam is a non-β-lactam β-lactamase inhibitor.

• This combination extends the activity of ceftazidime against resistant bacteria producing β-lactamases (including ESBLs, KPCs).

• Primarily used for treating complicated intra-abdominal infections, complicated urinary tract infections, hospital-acquired pneumonia, and ventilator-associated pneumonia.

• Administered intravenously (IV).

• Zidlife® is a Ceftazidime for Injection IP, a broad-spectrum third-generation cephalosporin antibiotic.

• It is effective against a wide range of Gram-negative and some Gram-positive bacteria.

• Commonly used for the treatment of serious infections, including pneumonia, sepsis, urinary tract infections, intra-abdominal infections, and skin infections.

• Suitable for intramuscular (IM) or intravenous (IV) administration.

• Xoind® contains Ceftriaxone Injection IP, a broad-spectrum third-generation cephalosporin antibiotic.

• Effective against a wide range of gram-positive and gram-negative bacterial infections.

• Can be administered intravenously (IV) or intramuscularly (IM).

• Supplied as a twin pack (typically includes sterile water for reconstitution).

MIKASURE® is an Amikacin Sulphate Injection IP used primarily to treat serious bacterial infections.
It belongs to the class of aminoglycoside antibiotics, effective against a broad spectrum of gram-negative bacteria.
It works by inhibiting bacterial protein synthesis, thus stopping the growth and multiplication of harmful bacteria.

Ideal for hospital use where severe infections require powerful antibiotic therapy, often reserved for infections resistant to other treatments.

Brunem-E Injection (1 g) is a sterile, lyophilized preparation of Doripenem, a broad-spectrum carbapenem antibiotic, formulated with EDTA as a stabilizer. It is designed for intravenous use in the treatment of serious and complicated bacterial infections, providing potent and rapid antibacterial action against a wide range of pathogens, including multidrug-resistant strains.

Doripenem works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It demonstrates excellent efficacy against gram-positive, gram-negative, and anaerobic bacteria.

• Rx-NEM™ 0.5 gm contains Meropenem Injection IP 500 mg.

• It is a broad-spectrum carbapenem antibiotic.

• Used for the treatment of a variety of serious bacterial infections.

• Administered intravenously (IV use only).

• Provided in a single-dose vial.

• Tazsure™ contains Piperacillin and Tazobactam Injection IP.

• It is a broad-spectrum antibiotic used to treat a variety of serious bacterial infections.

• Administered intravenously (IV).

• Provided as a single dose vial.

• Comes with a combipack containing sterile water for injection.

Brunem-E Injection contains Doripenem, a broad-spectrum carbapenem antibiotic effective against a wide range of gram-positive, gram-negative, and anaerobic bacteria. EDTA is included as a stabilizer to enhance the stability and potency of Doripenem.

Doripenem inhibits bacterial cell wall synthesis, leading to bacterial death. It is used in the treatment of severe or complicated infections such as intra-abdominal infections, urinary tract infections (including pyelonephritis), and nosocomial pneumonia, including ventilator-associated pneumonia.

• Rx-NEM™ 1 gm contains Meropenem Injection IP 1000 mg.

• A broad-spectrum carbapenem antibiotic.

• Designed for serious bacterial infections.

• Administered intravenously (IV use only).

• Supplied as a single-dose vial.

• Tazsure™ contains Piperacillin and Tazobactam Injection IP.

• It is a combination antibiotic effective against a wide range of bacterial infections.

• Intended for intravenous (IV) use only.

• Supplied as a single dose vial, along with sterile water for reconstitution.

• Tamley™ contains Levetiracetam Injection USP.

• It is used for the treatment of seizures.

• Administered by intravenous infusion.

• Designed for single use only.

• Supplied in a 5 ml vial.

Monostat® contains Tranexamic Acid Injection IP, a medication used to treat or prevent excessive bleeding.
It belongs to a class of drugs known as antifibrinolytics, which work by helping the blood clot normally, preventing prolonged bleeding.
It is commonly used in cases of heavy menstrual bleeding, surgical bleeding, trauma-related bleeding, and certain bleeding disorders.

Ideal for emergency and hospital settings where control of bleeding is critical.

NextBact-S is a combination of Cefoperazone and Sulbactam used for injection.

• Cefoperazone is a third-generation cephalosporin antibiotic effective against a wide range of bacteria.

• Sulbactam is a β-lactamase inhibitor, which enhances the effectiveness of cefoperazone by preventing bacterial resistance.

• This combination is used to treat severe bacterial infections such as respiratory tract infections, urinary tract infections, skin infections, intra-abdominal infections, and septicemia.

Esofree™ is a lyophilized Esomeprazole injection containing 40 mg per vial, used for intravenous (IV) administration. It is a proton pump inhibitor (PPI) that reduces gastric acid secretion, indicated in conditions requiring short-term treatment where oral therapy is not appropriate.

• RXCLAV™ is a combination antibiotic injection containing Amoxicillin and Potassium Clavulanate.

• It is used to treat a wide variety of bacterial infections.

• For IV (Intravenous) Use only.

Amoxicillin is a penicillin-type antibiotic, and Potassium Clavulanate is a beta-lactamase inhibitor that helps prevent bacteria from becoming resistant to Amoxicillin.

Hydrocortisone Sodium Succinate Injection IP

R-CORT is a fast-acting corticosteroid preparation used to manage severe allergic reactions, adrenal insufficiency, shock, and inflammatory conditions. It is administered either intramuscularly (IM) or intravenously (IV) for rapid relief in emergencies and critical care.

Freecid-IV contains Pantoprazole, a proton pump inhibitor (PPI) used to reduce stomach acid production. It is indicated for the treatment of acid-related disorders such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and gastric ulcers. This is a lyophilized powder formulation, meant for IV use only when oral administration is not possible.

• ZEROSICK-M® Injection is a combination of Mecobalamin (Vitamin B12), Pyridoxine Hydrochloride (Vitamin B6), Folic Acid, and Niacinamide (Vitamin B3).

• It is used for the treatment of vitamin B-complex deficiencies, peripheral neuropathy, anemia, nerve regeneration, and neuralgia.

• Suitable for intramuscular (IM) and intravenous (IV) administration.

• Helps improve nerve health, red blood cell production, and overall neurological function.